← Back to Search

Laser Therapy

Healthy Participants for Skin Pigmentation

N/A

Waitlist Available

Led By Jeffrey Kenkel, MD

Research Sponsored by University of Texas Southwestern Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up month 1 and month 3

Awards & highlights

Study Summary

This trial will test a new treatment for hyperpigmentation and melasma, using a device to deliver a combination of 1927 wavelengths of light. Patients will receive the treatment twice a month for two months, and then have follow-up visits at 1 and 3 months post-treatment.

Eligible Conditions

Skin Pigmentation

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ month 1 and month 3

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~month 1 and month 3

This trial's timeline: 3 weeks for screening, Varies for treatment, and month 1 and month 3 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Brown Spots

Change in Dyspigmentation Spots

Change in UV Spots

+3 more

Secondary outcome measures

Adverse Events

Change from Baseline of Skin Thickness

Change from Baseline of Skin Tissue Density

+1 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Healthy ParticipantsExperimental Treatment1 Intervention

Subjects who are interested in treatment for facial fine lines and wrinkles will be recruited for the study.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

MOXI

2022

N/A

~30

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Texas Southwestern Medical CenterLead Sponsor

1,048 Previous Clinical Trials

1,053,705 Total Patients Enrolled

Jeffrey Kenkel, MDPrincipal InvestigatorUT Southwestern

12 Previous Clinical Trials

233 Total Patients Enrolled

Abby Culver, MDPrincipal InvestigatorUT Southwestern

1 Previous Clinical Trials

20 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research study accommodate younger adults?

"This investigation has a narrow age requirement, limiting applicants to those between 20 and 60 years old. Conversely, 1 trial is available for minors and 3 other trials are open to patients that exceed 65 years of age."

Answered by AI

Is participation in this trial open to me?

"This trial is seeking 30 volunteers with skin issues aged between 20 and 60. All applicants must meet this criteria to be accepted."

Answered by AI

Are there currently any vacancies to participate in this experiment?

"The patient recruitment phase of this clinical trial appears to have concluded, as indicated on the clinicaltrials.gov website; specifically, it was initially posted on May 18th 2022 and underwent its last update June 3rd 2022. Nonetheless, there are 4 other medical studies actively enrolling patients at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Fractionated 1927nm Laser for Diffuse Pigmentation and Actinic Changes.

Abby Culver 2022. "Fractionated 1927nm Laser for Diffuse Pigmentation and Actinic Changes.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05226104.